Showing results (1401-1410 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|February 14, 2007
Gender difference in the pharmacokinetic interaction between oral warfarin and oxolamine in rats: inhibition of CYP2B1 by oxolamine in male ratsXuan Zhu, Dae Y Lee, Wan G ShinBiopharmaceutics & Drug Disposition|February 14, 2007
Recent advances in pharmacokinetic modelingAlaa M AhmadBiopharmaceutics & Drug Disposition|January 27, 2007
Effect of macrolide antibiotics on uptake of digoxin into rat liverSuwako Ito, Risa Nasu, Masayuki Tsujimoto, et al.Biopharmaceutics & Drug Disposition|December 19, 2006
Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjectsRameshraja Palaparthy, Rajendra S Pradhan, Jenny Chan, et al.Biopharmaceutics & Drug Disposition|August 2, 2007
Pharmacokinetics and metabolism of diltiazem in rats: comparing single vs repeated subcutaneous injections in vivoPollen K F Yeung, Angelita Alcos, Jinglan Tang, et al.Biopharmaceutics & Drug Disposition|January 1, 1991
Effect of H2-receptor antagonists on the pharmacokinetics of 5-fluorouracil in the rat and monkeyM R Dilloway, A F LantBiopharmaceutics & Drug Disposition|August 1, 1991
Diclofenac, paracetamol, and vidarabine removal during plasma exchange in polyarteritis nodosa patientsF Fauvelle, P Nicolas, A Leon, et al.Biopharmaceutics & Drug Disposition|November 23, 2006
In vitro metabolism of ciclesonide in human nasal epithelial cellsHideyuki Sato, Ruediger Nave, Takashi Nonaka, et al.Biopharmaceutics & Drug Disposition|May 1, 1992
Absorption and disposition of fluvastatin, an inhibitor of HMG-CoA reductase, in the rabbitF L Tse, D LabbadiaBiopharmaceutics & Drug Disposition|July 22, 2005
Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive ratsYu C Kim, Hyun J Shim, Joo H Lee, et al.Pageof 214